Vir Bio Ownership | Who Owns Vir Bio?

Overview Forecast RevenueFinancials Chart Transcripts

Vir Bio Ownership Summary

Vir Bio is owned by 89.34% institutional investors, 6.57% insiders, and 4.09% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.93% of VIR shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.08% of its assets in Vir Bio shares.

VIR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vir Bio	89.34%	6.57%	4.09%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	18.00M	12.93%	$161.27M
Blackrock	16.43M	12.15%	$146.26M
Sb investment advisers (uk)	16.68M	12.05%	$95.27M
Arch venture management	12.92M	9.28%	$115.73M
Vanguard group	12.55M	9.03%	$75.67M
Gsk	8.55M	6.14%	$76.62M
State street	7.14M	5.13%	$63.98M
Goldman sachs group	3.25M	2.33%	$29.12M
Morgan stanley	2.85M	2.05%	$25.57M
Geode capital management	2.66M	1.91%	$23.82M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	1.56M	23.22%	$13.88M
Arch venture management	12.92M	17.09%	$115.73M
Gsk	8.55M	12.79%	$76.62M
Superstring capital management lp	730.55K	4.68%	$6.55M
Alta partners management	509.92K	3.03%	$4.57M
Boxer capital management	1.87M	2.20%	$16.72M
Sio capital management	1.50M	1.93%	$13.43M
Avidity partners management lp	619.30K	1.43%	$6.33M
Soleus capital management	2.00M	0.73%	$17.94M
Sb investment advisers (uk)	16.68M	0.72%	$95.27M

Top Buyers

Holder	Shares	% Assets	Change
Soleus capital management	2.00M	0.73%	2.00M
Point72 asset management	1.95M	0.02%	1.76M
Goldman sachs group	3.25M	0.00%	1.68M
Blackrock funding, inc. /de	18.00M	0.00%	1.67M
Citadel advisors	2.10M	0.00%	1.61M

Top Sellers

Holder	Shares	% Assets	Change
Baillie gifford	-	-	-2.38M
Orbimed advisors	-	-	-2.38M
Abrdn	-	-	-1.39M
Balyasny asset management	-	-	-1.37M
Fmr	2.07M	0.00%	-1.09M

New Positions

Holder	Shares	% Assets	Change	Value
Soleus capital management	2.00M	0.73%	2.00M	$17.94M
Vanguard fiduciary trust	731.72K	0.00%	731.72K	$6.56M
Avidity partners management lp	619.30K	1.43%	619.30K	$6.33M
Empyrean capital partners, lp	527.80K	0.15%	527.80K	$4.73M
Parkman healthcare partners	500.00K	0.46%	500.00K	$4.48M

Sold Out

Holder	Change
Northwestern mutual wealth management	-5.00
Mendota financial group	-6.00
Dinuzzo private wealth	-6.00
Flagship harbor advisors	-14.00
Nelson, van denburg & campbell wealth management group	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	254	13.39%	124,391,567	7.66%	89	1.29%	183	92.63%	40	-51.81%
Dec 31, 2025	62	-72.20%	17,963,701	-83.21%	12	0.22%	21	-76.14%	27	-66.25%
Sep 30, 2025	79	-64.73%	21,507,831	-80.60%	15	0.24%	31	-70.19%	36	-41.94%
Jun 30, 2025	221	-6.75%	110,948,270	19.67%	80	1.76%	102	-18.40%	62	-11.43%
Mar 31, 2025	238	8.18%	93,178,710	4.94%	67	1.61%	125	10.62%	70	1.45%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	6.89M	4.08%	1.75K
Scottish Mortgage Ord	3.80M	2.78%	-
Vanguard US Total Market Shares ETF	3.46M	2.52%	-
Vanguard Total Stock Mkt Idx Inv	3.98M	2.36%	-
State Street® SPDR® S&P® Biotech ETF	2.82M	1.75%	-27.85K
Vanguard Small Cap Index	2.89M	1.72%	-10.38K
iShares Russell 2000 ETF	2.19M	1.30%	18.47K
SPDR® S&P Biotech ETF	1.61M	1.16%	3.59K
FIAM Small Cap Core Composite	1.78M	1.11%	-28.80K
Vanguard Small Cap Growth Index Inv	1.62M	0.96%	-1.26K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 01, 2026	Napolitano Janet	-	Sell	$30.24K
Jun 01, 2026	Sabatini Brent	SVP, Chief Accounting Officer	Sell	$3.58K
May 01, 2026	SATO VICKI L	-	Sell	$221.03K
Apr 06, 2026	De Backer Marianne	President and CEO	Sell	$664.35K
Apr 01, 2026	SATO VICKI L	-	Sell	$199.62K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	5
2026 Q1	-	20
2025 Q4	-	27
2025 Q3	-	5
2025 Q2	-	2

VIR Ownership FAQ

Who Owns Vir Bio?

Vir Bio shareholders are primarily institutional investors at 89.34%, followed by 6.57% insiders and 4.09% retail investors. The average institutional ownership in Vir Bio's industry, Biotech Stocks , is 35.75%, which Vir Bio exceeds.

Who owns the most shares of Vir Bio?

Vir Bio’s largest shareholders are Blackrock funding, inc. /de (18M shares, 12.93%), Blackrock (16.43M shares, 12.15%), and Sb investment advisers (uk) (16.68M shares, 12.05%). Together, they hold 37.13% of Vir Bio’s total shares outstanding.

Does Blackrock own Vir Bio?

Yes, BlackRock owns 12.15% of Vir Bio, totaling 16.43M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 146.26M$. In the last quarter, BlackRock decreased its holdings by -129K shares, a -0.78% change.

Who is Vir Bio’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is Vir Bio’s biggest shareholder by percentage of total assets invested, with 23.22% of its assets in 1.56M Vir Bio shares, valued at 13.88M$.

Who is the top mutual fund holder of Vir Bio shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Vir Bio shares, with 4.08% of its total shares outstanding invested in 6.89M Vir Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools